Cytek Biosciences, Inc. NASDAQ:CTKB

Cytek Biosciences stock price today

$4.04
-2.34
-36.78%
Financial Health
0
1
2
3
4
5
6
7
8
9

Cytek Biosciences stock price monthly change

+3.06%
month

Cytek Biosciences stock price quarterly change

+3.06%
quarter

Cytek Biosciences stock price yearly change

-32.24%
year

Cytek Biosciences key metrics

Market Cap
815.37M
Enterprise value
1.00B
P/E
477.5
EV/Sales
6.13
EV/EBITDA
104.97
Price/Sales
7.83
Price/Book
3.02
PEG ratio
-8.84
EPS
-0.08
Revenue
200.78M
EBITDA
-13.31M
Income
-11.51M
Revenue Q/Q
20.95%
Revenue Y/Y
20.91%
Profit margin
1.57%
Oper. margin
-1.1%
Gross margin
61.56%
EBIT margin
-1.1%
EBITDA margin
-6.63%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Cytek Biosciences stock price history

Cytek Biosciences stock forecast

Cytek Biosciences financial statements

Cytek Biosciences, Inc. (NASDAQ:CTKB): Profit margin
Jun 2023 49.69M -4.38M -8.83%
Sep 2023 48M -6.45M -13.45%
Dec 2023 58.23M 5.50M 9.45%
Mar 2024 44.86M -6.16M -13.75%
Cytek Biosciences, Inc. (NASDAQ:CTKB): Analyst Estimates
Sep 2025 61.54M 7.84M 12.74%
Oct 2025 61.11M 8.24M 13.49%
Dec 2025 74.05M 15.69M 21.2%
Mar 2026 59.2M -3.92M -6.62%
  • Analysts Price target

  • Financials & Ratios estimates

Cytek Biosciences, Inc. (NASDAQ:CTKB): Earnings per share (EPS)
2024-03-13 0.03 0.07
2024-05-08 -0.05 -0.05
Cytek Biosciences, Inc. (NASDAQ:CTKB): Debt to assets
Jun 2023 525054000 100.87M 19.21%
Sep 2023 519430000 103.90M 20%
Dec 2023 497669000 104.60M 21.02%
Mar 2024 492067000 99.45M 20.21%
Cytek Biosciences, Inc. (NASDAQ:CTKB): Cash Flow
Jun 2023 -2.85M 2.79M 216K
Sep 2023 -4.23M 43.12M -8.27M
Dec 2023 9.51M 29.06M -33.75M
Mar 2024 3.95M -5.75M 1.61M

Cytek Biosciences alternative data

Cytek Biosciences, Inc. (NASDAQ:CTKB): Employee count
Aug 2023 682
Sep 2023 699
Oct 2023 699
Nov 2023 699
Dec 2023 688
Jan 2024 688
Feb 2024 688
Mar 2024 676
Apr 2024 676
May 2024 676
Jun 2024 637
Jul 2024 637

Cytek Biosciences other data

43.52% +4.00%
of CTKB is owned by hedge funds
58.49M +5.57M
shares is hold by hedge funds

Cytek Biosciences, Inc. (NASDAQ:CTKB): Insider trades (number of shares)
Period Buy Sel
May 2023 0 43000
Jun 2023 0 43000
Jul 2023 0 43000
Aug 2023 0 43000
Sep 2023 0 43000
Oct 2023 0 43000
Nov 2023 0 43000
Dec 2023 0 23000
Mar 2024 0 40000
Apr 2024 0 21900
Transaction Date Insider Security Shares Price per share Total value Source
Option
BUSQUE PHILIPPE officer: SVP, GLOBAL SALES AND ..
Restricted Stock Units 2,210 N/A N/A
Option
BUSQUE PHILIPPE officer: SVP, GLOBAL SALES AND ..
Restricted Stock Units 1,536 N/A N/A
Option
BUSQUE PHILIPPE officer: SVP, GLOBAL SALES AND ..
Common Stock 2,210 N/A N/A
Option
BUSQUE PHILIPPE officer: SVP, GLOBAL SALES AND ..
Common Stock 1,536 N/A N/A
Option
BARNETT VALERIE officer: CHIEF LEGAL OFFICER
Restricted Stock Units 7,735 N/A N/A
Option
BARNETT VALERIE officer: CHIEF LEGAL OFFICER
Common Stock 7,735 N/A N/A
Option
BARNETT VALERIE officer: CHIEF LEGAL OFFICER
Common Stock 3,681 N/A N/A
Option
BARNETT VALERIE officer: CHIEF LEGAL OFFICER
Common Stock 2,016 N/A N/A
Option
BARNETT VALERIE officer: CHIEF LEGAL OFFICER
Restricted Stock Units 3,681 N/A N/A
Option
BARNETT VALERIE officer: CHIEF LEGAL OFFICER
Restricted Stock Units 2,016 N/A N/A
Wednesday, 20 November 2024
globenewswire.com
Tuesday, 19 November 2024
globenewswire.com
Thursday, 7 November 2024
globenewswire.com
Tuesday, 5 November 2024
seekingalpha.com
zacks.com
Wednesday, 18 September 2024
globenewswire.com
Thursday, 12 September 2024
globenewswire.com
Wednesday, 21 August 2024
globenewswire.com
Sunday, 11 August 2024
seekingalpha.com
Tuesday, 6 August 2024
zacks.com
Tuesday, 30 July 2024
globenewswire.com
Monday, 24 June 2024
zacks.com
Thursday, 30 May 2024
globenewswire.com
Tuesday, 28 May 2024
globenewswire.com
Thursday, 23 May 2024
seekingalpha.com
Monday, 20 May 2024
globenewswire.com
Sunday, 12 May 2024
Seeking Alpha
Wednesday, 8 May 2024
Zacks Investment Research
Tuesday, 30 April 2024
GlobeNewsWire
Monday, 29 April 2024
GlobeNewsWire
Friday, 26 April 2024
Zacks Investment Research
Thursday, 11 April 2024
Zacks Investment Research
Wednesday, 10 April 2024
Zacks Investment Research
Tuesday, 2 April 2024
Zacks Investment Research
Wednesday, 20 March 2024
Seeking Alpha
Wednesday, 28 February 2024
Seeking Alpha
Wednesday, 21 February 2024
Zacks Investment Research
Wednesday, 7 February 2024
GlobeNewsWire
GlobeNewsWire
Tuesday, 9 January 2024
Zacks Investment Research
  • What's the price of Cytek Biosciences stock today?

    One share of Cytek Biosciences stock can currently be purchased for approximately $4.04.

  • When is Cytek Biosciences's next earnings date?

    Unfortunately, Cytek Biosciences's (CTKB) next earnings date is currently unknown.

  • Does Cytek Biosciences pay dividends?

    No, Cytek Biosciences does not pay dividends.

  • How much money does Cytek Biosciences make?

    Cytek Biosciences has a market capitalization of 815.37M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 17.67% to 193.02M US dollars. Cytek Biosciences made a loss 12.15M US dollars in net income (profit) last year or -$0.05 on an earnings per share basis.

  • What is Cytek Biosciences's stock symbol?

    Cytek Biosciences, Inc. is traded on the NASDAQ under the ticker symbol "CTKB".

  • What is Cytek Biosciences's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of Cytek Biosciences?

    Shares of Cytek Biosciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Cytek Biosciences's key executives?

    Cytek Biosciences's management team includes the following people:

    • Dr. Wenbin Jiang Ph.D. Pres, Chief Executive Officer & Director(age: 61, pay: $353,120)
    • Dr. Ming Yan Ph.D. Chief Technology Officer & Director(age: 62, pay: $340,530)
    • Mr. Patrik Sebastian Jeanmonod Chief Financial Officer(age: 59, pay: $340,110)
  • How many employees does Cytek Biosciences have?

    As Jul 2024, Cytek Biosciences employs 637 workers, which is 6% less then previous quarter.

  • When Cytek Biosciences went public?

    Cytek Biosciences, Inc. is publicly traded company for more then 4 years since IPO on 23 Jul 2021.

  • What is Cytek Biosciences's official website?

    The official website for Cytek Biosciences is cytekbio.com.

  • Where are Cytek Biosciences's headquarters?

    Cytek Biosciences is headquartered at 47215 Lakeview Boulevard, Fremont, CA.

  • How can i contact Cytek Biosciences?

    Cytek Biosciences's mailing address is 47215 Lakeview Boulevard, Fremont, CA and company can be reached via phone at 877 922 9835.

Cytek Biosciences company profile:

Cytek Biosciences, Inc.

cytekbio.com
Exchange:

NASDAQ

Full time employees:

645

Industry:

Medical - Devices

Sector:

Healthcare

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, which are automated plate loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

47215 Lakeview Boulevard
Fremont, CA 94538

CIK: 0001831915
ISIN: US23285D1090
CUSIP: 23285D109